Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia

You need to have your doctor test for these biomarkers because of your likely chance of dementia. Then you need your doctor's SPECIFIC DEMENTIA PREVENTION PROTOCOLS applied.  No protocol, fire that doctor.

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018

 

Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia

JAMA — Jack CR, et al. | June 20, 2019

Via performing a longitudinal cohort study that included 480 participants without dementia (aged 60 years or older), researchers ascertained the associations between amyloid, tau, and neurodegeneration biomarker profiles and memory decline, and determined if biomarkers rendered incremental prognostic value beyond more readily available clinical and genetic information. Among older persons without baseline dementia, when followed up for a median of 4.8 years, a little but statistically meaningful improvement in the prediction of memory decline over a model with more readily available clinical and genetic variables was observed through a prediction model that included amyloid positron emission tomography (PET), tau PET, and magnetic resonance imaging cortical thickness. However, the uncertainty of the clinical importance of this difference was noted.

Read the full article on JAMA